Biomet Orthopedics, LLC
18
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
66.7%
12 terminated/withdrawn out of 18 trials
29.4%
-57.1% vs industry average
0%
0 trials in Phase 3/4
60%
3 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System
Role: lead
A Clinical Investigation of the Discovery™ Elbow System
Role: lead
Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia
Role: lead
A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems
Role: lead
A Clinical Investigation of the Taperloc® Microplasty™ Hip System
Role: lead
A Clinical Investigation of the C2a-Taper™ Acetabular System
Role: lead
A Clinical Investigation of the M2a- 38™ Hip System
Role: lead
A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty
Role: lead
A Clinical Investigation of the M2a- Taper™ Hip System
Role: lead
A Clinical Investigation of the Oxford® Partial Knee System
Role: lead
A Clinical Investigation of the Copeland™ Humeral Resurfacing Head
Role: lead
ExploR® Modular Radial Head Data Collection
Role: lead
I-beam and Cruciate Tibial Components Used in Total Knee Replacement
Role: lead
A Clinical Investigation of the M2a-Magnum™ Hip System
Role: lead
A Clinical Investigation of the Balance® Microplasty™ Hip System
Role: lead
Total Knee Replacement With Duracon® and Vanguard™ Prostheses
Role: lead
Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement
Role: lead
Direct Anterior Versus Posterior Total Hip Arthroplasty Surgical Approaches
Role: collaborator
All 18 trials loaded